Management of Uterine Fibroids

Management of Uterine Fibroids, a new report from AHRQ's Effective Health Care Program, says a range of treatments, including surgery and medications, is effective for removing or shrinking uterine fibroids, but a woman should discuss her individual needs and preferences with her doctor before choosing a treatment.

About 26 million U.S. women between 15 and 50 have at least one uterine fibroid, which is a growth that forms in the uterine muscle. Fibroids are noncancerous but can cause severe pain, cramping, excessive bleeding, and anemia. Treatment choices often are made according to a woman's age and desire to maintain her fertility, as several treatments can cause infertility.

AHRQ's report also reviewed evidence about the risk of spreading an unsuspected cancer of the uterus during uterine fibroid surgery. Evidence shows the use of a power morcellator, an instrument that divides and removes tissue masses during laparoscopic surgery, might spread a hidden cancer and reduce survival odds.

Select to access of Management of Uterine Fibroids.

Page last reviewed December 2017
Page originally created December 2017
Internet Citation: Management of Uterine Fibroids. Content last reviewed December 2017. Agency for Healthcare Research and Quality, Rockville, MD.